A Study to Investigate LYL845 in Adults With Solid Tumors

Clinical trial NCT05573035 · TERMINATED

Trial details

NCT number: NCT05573035
Sponsor: Lyell Immunopharma, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Non-small Cell Lung Cancer Colorectal Cancer

Start date: 2022-12-19
Primary completion: 2025-01-09
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.